We are live on ! Find out more
CYTHW

Cyclo Therapeutics, Inc. Warrant
CYTHW

Delisted

CYTHW was delisted on the 25th of March, 2025.

Back to rankings

6 hedge funds and large institutions have $2.05M invested in Cyclo Therapeutics, Inc. Warrant in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$238K
2
WVP
Worth Venture Partners
New Jersey
+$109K
3
CH
CVI Holdings
Delaware
+$72.8K
4
AC
Armistice Capital
New York
+$61.7K
5
UBS Group
UBS Group
Switzerland
+$2.28K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$1.52M +$432K +350,000 New
SM
2
Sabby Management
Florida
$208K +$238K +193,012 New
AC
3
Armistice Capital
New York
$156K +$61.7K +50,000 New
WVP
4
Worth Venture Partners
New Jersey
$96K +$109K +88,690 New
CH
5
CVI Holdings
Delaware
$64K +$72.8K +59,000 New
UBS Group
6
UBS Group
Switzerland
$2K +$2.28K +1,848 New

CYTHW Hedge Fund Activity: Q4 2020 in Review

6 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q4 2020, worth a combined $2.05M.

Buyers outnumbered sellers: 6 funds opened new CYTHW positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $238K.

  • 6 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $2.05M of Cyclo Therapeutics, Inc. Warrant stock for Q4 2020.
  • 6 funds opened new Cyclo Therapeutics, Inc. Warrant positions in Q4 2020 and 0 closed out, a net change of +6 holders.
  • The largest Cyclo Therapeutics, Inc. Warrant buyer in Q4 2020 was Sabby Management, an estimated $238K added.

Based on aggregated 13F filings for Q4 2020.